Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Blog
  • Automation
  • Partnering with purpose: The NSW Newborn Screening Programme with advanced automation.
Partnering with Purpose: The NSW Newborn Screening Programme with advanced automation

Blog

Automation

Oct 10th 2025

2 min read

Partnering with purpose: The NSW Newborn Screening Programme with advanced automation.

Help us improve your Revvity blog experience!

Feedback

Every year, over 100,000 newborns in New South Wales are screened for a wide array of disorders-an essential public health initiative that demands speed, accuracy, and efficiency. As the number of disorders increased, so did the need for smarter solutions. That's where Revvity stepped in.

To supercharge the workflow, a state-of-the-art robotic system was installed to streamline sample preparation for mass spectrometry analysis. The result? Faster turnaround times, enhanced precision, and a dramatically reduced workload for lab teams.

Revvity's automation isn't just filling a gap-it's setting a new standard for newborn screening excellence. 

Our collaboration with NSW Newborn Screening Programme

We're proud to partner with the NSW Newborn Screening Program, which plays a vital role in safeguarding the health of newborns across the state. The screening involves a simple heel prick test performed within the first few days of a baby's life. This test can identify early indicators of a range of congenital metabolic disorders-many of which may not show symptoms immediately.

Early detection means that affected children can begin receiving care and treatment promptly, giving them the best possible start in life.

In 2025 July, The NSW Newborn Screening Programme has been enhanced with Revvity Cell explorer™ G3 integrated automation systems, bringing advanced automation that delivers faster results for your precious little one. You can check 2 automation systems that Revvity crew and NSW Newborn Screening team worked together in the video below:

AWS exploer G3 collaboration thumbnail

This innovation means earlier detection of potential health concerns, leading to timely interventions and better outcomes for your baby. Every family deserves peace of mind during those crucial early days, and this technology helps make that possible.

Why Revvity?

Streamlined, Scalable, and Smart: Automated Sample Prep for NeoBase2 and NeoLSD

Deliver a fully automated solution for NeoBase2 and NeoLSD mass spectrometry sample preparation-designed to transform complex workflows into seamless operations.

  • Minimize human error: Eliminate variability in a traditionally long, multi-step extraction process with precision automation.
  • User-friendly interface: Intuitively designed for lab staff, ensuring ease of use without extensive training.
  • High-throughput performance: Built to handle large-scale screening demands with speed and consistency.
  • End-to-end sample traceability: Maintain full visibility and control from start to finish.
  • True walkaway operation: Enjoy minimal intervention with a setup that runs independently-freeing up valuable time and resources.

Revvity's automated prep system isn't just efficient-it's a game-changer for modern newborn screening labs.

Revvity's core value

Our newborn screening workflows have been designed with accuracy, speed and robustness at their core. Whether you are launching a new newborn screening service or are looking for the very latest in automated and technological advances, we offer newborn screening solutions that can support your laboratory objectives.

Our commitment to your child's health begins from day one, giving every newborn the best possible start in life.

Contact us


For research use only. Not for use in diagnostic procedures.

Help us improve your Revvity blog experience!

Feedback

Share this post:

  • Email
  • Facebook
  • Linkedin
  • Twitter

続き Automation posts

The need for NGS automation for single-cell and spatial omics.
Read
Embracing modularity: flexible automation's role in drug discovery research.
Read
Speeding up sample prep TAT from tough research biospecimens
Read
line

Questions?
We’re here to help.

Contact us
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.